Amineptine

This classification denotes an antidepressant agent with the molecular formula C22H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 27T1I13L6G, chemically known as 7-((10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)amino)heptanoic acid but generally known as amineptine, which bears US NIH Compound Identifier 34870. Amineptine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amineptine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05435MIG. The term AMINEPTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules amineptine in its Anatomical Therapeutic Chemical (ATC) Classification. AMINEPTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amineptine under HS 29224995 and SITC 51465. As of Q4 2014, AMINEPTINE remains the US FDA Preferred Term for this commodity. Amineptine bears US NLM identifiers UMLS ID C0051607 and NCI Concept Code C74142. SMILES: OC(=O)CCCCCCNC1C2C(CCC3C1CCCC3)CCCC2.